Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the Department of Health and Human Services (HHS) and the Department of Commerce (DOC) ...

Manufacturers are pushing for higher prices overseas, but face political and economic resistance.

What the deals have in common is price reductions for Medicaid, MFN prices for new launches, and discounts for self-paying ...

After U.S. President Donald Trump took the stage at the World Economic Forum this week to tout the supposed success of his ...

Yellow Corp. urged a judge to approve settlements with multiemployer pension plans aimed at resolving billions of dollars in ...

Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter blanket’ approach to drug pricing for small companies.

"The Great Healthcare Plan" aims to lower drug costs, reduce premiums, and enhance price transparency, with a focus on Most ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "MFN reinforces the worst incentives in 340B, shifts costs ...

Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...

Earlier this year, when the administration proposed deep cuts to the National Institutes of Health, lawmakers from both parties swiftly and rightly pushed back. Slashing medical research funding, they ...

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...

Abbvie Inc. announced its agreement to focus on improving access and lowering the cost of medicines, becoming the latest pharma to fall in line with the Trump administration’s most-favored nation (MFN ...